In Japanese patients with type 2 diabetes, baseline carotid IMT and average HbA1c predict IMT progression, while baseline IMT and low HDL cholesterol predict incident nonfatal CHD.
No takes yet. Share an insight, caveat, or question.
Does not support changing CHD risk assessment in T2DM; leaves open whether targeting IMT or HDL improves outcomes.
Yamasaki et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: